A large quasi-experimental study in Australia found that adults eligible for free shingles vaccination based on their date of ...

Vaccination with GSK's recombinant shingles vaccine, Shingrix, could delay the onset of dementia, according to researchers in the UK. A study published in Nature Medicine suggests that people ...

Shingrix is a non-live, recombinant vaccine, developed to help prevent shingles and its complications. A phase 3 clinical trial programme showed that by reducing the incidence of shingles ...

Thus far in the calendar year 2025, the stock price of GSK Pharma has zoomed 40 per cent, as against 1.8 per cent rise in BSE ...

Shingles Awareness Week Survey. Data on file. 2025.Han R. et. al., (2022, November 23) Public Health Impact of Introducing an Adjuvanted Recombinant Zoster Vaccine in the Philippines [Poster ...

You’re reading The Checkup With Dr. Wen, a newsletter on how to navigate medical and public health challenges. Click here to ...

Zostavax and Shingrix are linked to protection for older adults in multiple studies.

Dr. David Winter of Baylor Scott and White discusses the new study on the shingles vaccine. Trump administration asks Supreme Court to allow ban on transgender military troops McDonald’s is adding its ...

A vaccine designed to help protect you from an extremely painful viral infection has another important benefit. A new study ...

There is new evidence that a vaccine available right now to prevent shingles can also lower your risk for dementia.